Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Angiotensin-Converting Enzyme 2 - an overview | ScienceDirect Topics
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 | Signal Transduction and Targeted Therapy
Angiotensin-Converting Enzyme II in the Heart and the Kidney | Circulation Research
Angiotensinkonvertierendes Enzym 2 (ACE2): Rolle in der Pathogenese von Erkrankungen außerhalb von COVID-19 | Die Nephrologie
A hypothesis for pathobiology and treatment of COVID‐19: The centrality of ACE1/ACE2 imbalance - Sriram - 2020 - British Journal of Pharmacology - Wiley Online Library
Allosteric Site of ACE-2 as a Drug Target for COVID-19 | ACS Pharmacology & Translational Science
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19 | Hypertension Research
Angiotensin and the Coronavirus | Science | AAAS
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target | Intensive Care Medicine
Downregulation of ACE2 induces overstimulation of the renin–angiotensin system in COVID-19: should we block the renin–angiotensin system? | Hypertension Research
ACE inhibition, ACE2 and angiotensin-(1⿿7) axis in kidney and cardiac inflammation and fibrosis - ScienceDirect
View of The regulation of ACE-2 in the heart and lungs | The Southwest Respiratory and Critical Care Chronicles
Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic | Aging
ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues | Human Genomics | Full Text
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
COVID-19: Der Einfluss von Antihypertonika
ACE2 – das missbrauchte Multitalent | Die Nephrologie
COVID-19 and ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury | Revista Colombiana de Cardiología
ACE2, a new regulator of the renin–angiotensin system: Trends in Endocrinology & Metabolism
ACE2 as a potential therapeutic target for pandemic COVID-19 - RSC Advances (RSC Publishing) DOI:10.1039/D0RA08228G
